受强制性开放获取政策约束的文章 - Muhammed Iraqi了解详情
可在其他位置公开访问的文章：8 篇
Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors
R Keshet, JS Lee, L Adler, M Iraqi, Y Ariav, LQJ Lim, S Lerner, ...
Nature Cancer 1 (9), 894-908, 2020
强制性开放获取政策： US National Institutes of Health, European Commission
The Ebola-glycoprotein modulates the function of natural killer cells
A Edri, A Shemesh, M Iraqi, O Matalon, M Brusilovsky, U Hadad, ...
Frontiers in immunology 9, 1428, 2018
强制性开放获取政策： US National Science Foundation
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity
A Ottolenghi, P Bolel, R Sarkar, Y Greenshpan, M Iraqi, S Ghosh, ...
Scientific Reports 11 (1), 7676, 2021
强制性开放获取政策： US National Science Foundation, Helmholtz Association
N-Glycans mediate the ebola virus-GP1 shielding of ligands to immune receptors and immune evasion
M Iraqi, A Edri, Y Greenshpan, K Kundu, P Bolel, A Cahana, A Ottolenghi, ...
Frontiers in cellular and infection microbiology 10, 48, 2020
强制性开放获取政策： US National Science Foundation
Blocking the PCNA/NKp44 checkpoint to stimulate NK cell responses to multiple myeloma
M Iraqi, A Edri, Y Greenshpan, O Goldstein, N Ofir, P Bolel, M Abu Ahmad, ...
International Journal of Molecular Sciences 23 (9), 4717, 2022
强制性开放获取政策： US National Science Foundation, US National Institutes of Health, Helmholtz …
Rapid response to the combination of lenvatinib and pembrolizumab in patients with advanced carcinomas (Lung adenocarcinoma and malignant pleural mesothelioma)
W Shalata, M Iraqi, B Bhattacharya, V Fuchs, LC Roisman, AY Cohen, ...
Cancers 13 (14), 3630, 2021
强制性开放获取政策： US National Science Foundation, Helmholtz Association
CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma
E Remer, M Badarni, E Hikri, A Dayan, L Levi, A Popovtzer, M Iraqi, ...
Journal of Clinical Medicine 9 (10), 3214, 2020
强制性开放获取政策： US National Science Foundation, US National Institutes of Health
NKp44-derived peptide used in combination stimulates antineoplastic efficacy of targeted therapeutic drugs
M Iraqi, P Bolel, R Sarkar, B Bhattacharya, M Abu Ahmad, A Edri, ...
International Journal of Molecular Sciences 23 (22), 14054, 2022
强制性开放获取政策： US National Science Foundation, Helmholtz Association
出版信息和资助信息由计算机程序自动确定